Natural killer (NK) cells are important component of innate immunity and also contribute to activating and reshaping the adaptive immune responses. The functions of NK cells are modulated by multiple inhibitory and stimulatory receptors. Among these receptors, the activating receptor CD226 (DNAM-1) mediates NK cell activation via binding to its nectin-like (Necl) family ligand, CD155 . Here, we present a unique side-by-side arrangement pattern of two tandem immunoglobulin V-set (IgV) domains deriving from the ectodomains of both human CD226 (hCD226-ecto) and mouse CD226 (mCD226-ecto), which is substantially different from the conventional head-to-tail arrangement of other multiple Ig-like domain molecules. The hybrid complex structure of mCD226-ecto binding to the first domain of human CD155 (hCD155-D1) reveals a conserved binding interface with the first domain of CD226 (D1), whereas the second domain of CD226 (D2) both provides structural supports for the unique architecture of CD226 and forms direct interactions with CD155. In the absence of the D2 domain, CD226-D1 exhibited substantially reduced binding efficacy to CD155. Collectively, these findings would broaden our knowledge of the interaction between NK cell receptors and the nectin/Necl family ligands, as well as provide molecular basis for the development of CD226-targeted antitumor immunotherapeutics.
Natural killer (NK) cells are important component of innate immunity and also contribute to activating and reshaping the adaptive immune responses. The functions of NK cells are modulated by multiple inhibitory and stimulatory receptors. Among these receptors, the activating receptor CD226 (DNAM-1) mediates NK cell activation via binding to its nectin-like (Necl) family ligand, CD155 (Necl-5). Here, we present a unique side-by-side arrangement pattern of two tandem immunoglobulin V-set (IgV) domains deriving from the ectodomains of both human CD226 (hCD226-ecto) and mouse CD226 (mCD226-ecto), which is substantially different from the conventional head-to-tail arrangement of other multiple Ig-like domain molecules. The hybrid complex structure of mCD226-ecto binding to the first domain of human CD155 (hCD155-D1) reveals a conserved binding interface with the first domain of CD226 (D1), whereas the second domain of CD226 (D2) both provides structural supports for the unique architecture of CD226 and forms direct interactions with CD155. In the absence of the D2 domain, CD226-D1 exhibited substantially reduced binding efficacy to CD155. Collectively, these findings would broaden our knowledge of the interaction between NK cell receptors and the nectin/Necl family ligands, as well as provide molecular basis for the development of CD226-targeted antitumor immunotherapeutics.
NK cell receptor | DNAM-1 | Necl-5 | complex structure A s a subpopulation of immune lymphocytes, natural killer (NK) cells respond early to viral infection and malignancies in innate immunity by cell-mediated cytotoxicity (1) . NK cells also help activate and reshape the adaptive immune responses via secreted cytokines (1) . The activities of NK cells are modulated by various receptors, which can be grouped into stimulatory or inhibitory receptors according to the signals they transduced (2) (3) (4) (5) (6) . Most of the inhibitory receptors recognize the major histocompability complex class I (MHC-I or HLA-I in human) molecules and mediate the self-tolerance of MHC-I expressing cells (7, 8) . NK cells can respond to MHC-I-deficient cells via a missing self strategy, in which the NK cells can be activated by excessive activating signals and kill tumor cells or virus-infected cells with reduced expression of MHC-I molecules (9) .
Several primary receptor families of NK cells consist of paired stimulatory and inhibitory members, which bind to shared ligands (10) . These receptors harmonize the NK cell functions via a supposed affinity-dependent inhibitory receptor first mechanism (11) . Examples of these paired receptor families include the LY49 family in mouse, the killer cell immunoglobulin-like receptors (KIR) family in human, and the CD94-NKG2 heterodimers in both human and mouse (1, 8) . A paired receptor family, which specifically recognizes the nectin and nectin-like (Necl) family members, was latterly discovered (12) . These emerging receptors are activating receptors CD226 (13) and class I restricted T cell-associated molecule (14) , as well as inhibitory receptors T cell Ig and immunoreceptor tyrosinebased inhibitory motif domain (TIGIT) (15) and CD96 (16) . These paired receptors are reported to mediate both immune recognition and cell adhesion (17, 18) . CD226, also known as DNAM-1, belongs to the Ig superfamily and contains two extracellular Ig-like domains (CD226-D1 and CD226-D2), and is widely expressed in monocytes, platelets, T cells, and most of the resting NK cells (8, 13, 19, 20) . The intracellular domain of CD226 does not contain a tyrosine-based activation motif, which is accepted as responsible for activating signal transduction of stimulatory molecules (13) . Instead, it transmits the downstream signaling by phosphorylation of intracellular phosphorylation sites and subsequent association with integrin lymphocyte function-associated antigen 1 (21) . Accumulating evidence supports that the interactions between CD226 and its nectin/Necl family ligands, namely, CD155 (also known as PVR or Necl-5) and CD112 (nectin-2), play pivotal roles in modulating NK cell adhesion and cytotoxicity, facilitating immunological synapse formation and promoting cytokine secretion during inflammation (22, 23) . The expression levels of CD155 and CD112 are up-regulated in tumor cells (24) . In fact, several publications report that CD226 enhances the cytotoxicity of NK cells against various tumor cells, both in vitro and in vivo, and plays a critical role in tumor immunosurveillance (13, 25, 26) . The CD155 and CD112 molecules can also be recognized by paired inhibitory receptors, TIGIT or CD96, the functions of which have been verified to counterbalance CD226-dependent NK cell activation (15, (27) (28) (29) . Moreover, a recent study finds that Cd96 −/− mice exhibit resistance to carcinogenesis and lung Significance CD226/DNAM-1 is a stimulatory molecule expressed in natural killer (NK) cells; it plays critical roles in regulating NK cell functions via binding to its ligand, CD155. Here, we explore the molecular basis of the interaction between activating receptor CD226 and CD155 by determining the structures of both apo CD226 and the CD226-CD155 complex. CD226 exhibits a unique side-by-side arrangement pattern of its two immunoglobulin V-set (IgV) domains, which is substantially different from all the known Ig-like molecules with the exception of one from amphioxus (VCBP3). The binding profiles of CD226 and CD155 revealed that both of the two IgV domains participate in ligand binding. Our studies structurally support a better understanding of NK cell activation and would facilitate development of biologics for tumor immunotherapy.
metastases, indicating an opposite role for CD96 in tumor rejection (28) . All these findings suggest that the paired receptors of the CD226-TIGIT-CD96 family play critical roles in coordinating NK cell functions and may serve as potential targets for antitumor immunotherapy. However, the molecular basis for the interaction between these paired receptors and ligands is not fully understood, which has limited our understanding of the regulation of NK cell functions. To date, only complex structures of the inhibitory receptor TIGIT with either CD155 or CD112 have been reported (18, 30) . In the present study, the molecular basis of the interaction between CD226 and CD155 was investigated. Compared with the head-to-tail arrangement of the Ig-like domains of all of the known Ig-like superfamily molecules, CD226 exhibits a unique side-by-side arrangement of its two immunoglobulin V-set (IgV) domains. We found that CD226-D1 has engaged in the binding to CD155 via a conserved binding interface, whereas CD226-D2 plays critical roles in both supporting the architecture of CD226 and in direct recognition of CD155. Taken together, these findings would broaden our knowledge of the interaction between CD226-TIGIT-CD96 receptors and the nectin/Necl family ligands and, moreover, provide clues for the development of biologics targeting CD226 for tumor immunotherapy.
Results
Overall Structure of the Two IgV-Like Domain CD226. The ectodomain of human CD226 (hCD226-ecto) was expressed in Escherichia coli cells as inclusion bodies, and the soluble protein was subsequently obtained by in vitro refolding (17) . The molecular weight of the monomeric hCD226-ecto is ∼26 kDa, based on both prediction from its amino acid sequence and SDS/PAGE analysis (SI Appendix, Fig. S1 ). The purified hCD226-ecto protein was then crystallized. Because the attempts for phase determination by the molecular replacement phasing method did not work, selenomethionine crystals were prepared by streak seeding twice, with the native crystals as seeds. The structure of hCD226-ecto was subsequently solved via the single wavelength anomalous dispersion phasing method. The native and selenomethionine crystals of hCD226-ecto were isomorphous and diffracted to resolutions of 2.5 and 2.7 Å, respectively (SI Appendix, Table S1 ).
High electron density from residues V21 to A241, which covers the two Ig-like domains of hCD226-ecto, could be observed ( Fig. 1 A and B) . For each domain of hCD226-ecto, the amino acids were arranged into a canonical V-set arrangement pattern with nine strands constituting two β-sheets: strands B, E, and D, as well as strands A, G, F, C, C′, and C″ (Fig. 1C) . Three small helices located between the E and F strands in both D1 and D2 (η2 for D1 and η4 for D2) and between the C″ and D strands of D1 (η1) further decorate the IgV folds. The conserved disulfide bond bridging strand B to strand F was observed in both D1 and D2 (Fig. 1C) . In addition, a disulfide bond exists at the C′ edge of D2, which stabilizes the loop connecting strand C′ and E.
Unique Side-by-Side Two-IgV Arrangement of CD226. In contrast to the conserved beads-on-a-string pattern of Ig-like molecules with multiple sequential Ig-like domains, the arrangement pattern of the two IgV domains of CD226 is unique. In the canonical arrangement model of multiple Ig-like domain molecules, the tandem Ig-like domains usually line up along their longitudinal axis, with varied interdomain angles. This arrangement is displayed by numerous immunological synapse molecules possessing different numbers of Ig-like domains, such as PD-L1, nectin-1, and CD4, which contain two, three, and four Ig-like domains, respectively (31) (32) (33) . The linkages between these domains are flexible loops, as shown in CD4 (the linker between D2 and D3; Fig. 2A ), nectin-1 (Fig. 2B) , and PD-L1 (Fig. 2C) , or a rigid connection, represented by the β strands connecting D1-D2 or D3-D4 in CD4 ( Fig. 2A) .
Unlike the prototypical head-to-tail structures described here, a unique side-by-side arrangement pattern is presented by the tandem IgV domains of CD226 (Fig. 1A) . The connecting loop between D1 and D2, which contains the third small helix (η3) of hCD226-ecto, stretches across the AGFCC′ sheet of D2 and surrounds the entire D2 domain as an arm ( Fig. 1 A and C) . The conformation of this arm linker is further stabilized by hydrogen bond interactions formed by amino acids from the CC′ loop (P170) and G strand (V235 and R237) of the D2 domain ( Fig. 2 D and E) .
Of note, the A strand of D1 (D1-A strand), which is located in the center of the entire hCD226-ecto structure, forms two sets of strong hydrogen bond networks with both the G strand of D1 and the C′C″ edge of D2 (Fig. 2 D and F) . As a consequence, the AGFCC′C″ sheet of D1 stretches toward the AGFCC′ sheet of D2 and forms a tightly bonded super-β-sheet of 11 β strands. In addition, this super β-ladder is spirally arranged on the longitudinal axis and forms a spiral-staircase-like structure with a near 180°twirled angel, counting from the beginning of the super β-ladder (C″ strand of D1) to the end (A strand of D2; Fig. 2D ). Four hCD226 single-site mutants with V21A, L22A, H24A, or S26A from the D1-A strand, which form multiple hydrogen bond interactions with D2 domain, together with a quadruply mutated hCD226 (hCD226A-VLHS) and an A strand (V21-P28) truncated hCD226 (hCD226-ΔA strand) were further analyzed with thermofluor assay to investigate the influences of these mutations to the stability of CD226. The results showed that all the four single mutations have destabilized hCD226 compared with wild-type hCD226 (Fig. 2G) . Specifically, H24A single mutation has dramatically destabilized hCD226 by 10°C, which is similar to the quadruple-mutant hCD226A-VLHS and the A strand truncated mutant hCD226-ΔA strand. These results indicate that H24 of D1 may contribute major supports for the unique scaffold of CD226.
To exclude the possibility that this unique architecture in hCD226-ecto may result from misfolding during the protein refolding process, we determined the structure of the ectodomain of mouse CD226 (mCD226-ecto), which shares 54% amino acid homology with hCD226-ecto (SI Appendix, Fig. S2 and Table  S1 ). We found that mCD226-ecto exhibits a similar structure to hCD226-ecto, with a root mean square deviation of 1.5 Å over 221 aligned Cα atoms (Fig. 2H ). The side-by-side arrangement of the two IgV domains was only observed before in variable-regioncontaining chitin-binding protein 3 (VCBP3), an Ig-like molecule in amphioxus (Branchiostoma floridae) that contains two N-terminal IgV domains and a C-terminal chitin-binding domain in its ectodomain (Fig. 2I) . Unlike the arrangement of translational symmetry exhibited by the two IgVs of CD226, the arrangement of the two IgVs in VCBP3 has rotational symmetry that centers on the anti-parallel G strand flank of each domain.
Binding Profiles of CD226 and CD155. We next analyzed the binding profiles of CD226 and CD155. The first IgV domain of human CD155 (hCD155-D1), which is responsible for receptor binding as shown in the TIGIT-CD155 complex structure (18) , was expressed in the baculovirus expression system. However, the low refolding efficiency of hCD226-ecto presented as an obstacle in acquisition of CD226-CD155 complex crystals, which requires massive amounts of highly purified protein. Accordingly, we set our sights on replacing hCD226-ecto with its mouse ortholog that shares high structural similarity and can be refolded more efficiently.
The binding profiles between h/mCD226-ecto and hCD155-D1 were investigated using analytical gel-filtration and surface plasmon resonance (SPR) assays. Both hCD226-ecto and mCD226-ecto formed stable complexes with hCD155-D1 in solution (Fig. 3 A  and B) . The SPR binding profiles revealed that mCD226-ecto binds to hCD155-D1 (K D = 2.4 μM) with similar binding kinetics, rapid on-rate and off-rate, and affinity to that of hCD226-ecto (K D = 1.4 μM; Fig. 3 C-F) . Considering the structural and binding similarities between hCD226-ecto and mCD226-ecto, we postulate that the interaction between mCD226-ecto and CD155 is similar to that of hCD226-ecto and CD155. Therefore, the mCD226-ecto/hCD155-D1 complex proteins were used for crystal screening, and the complex structure was analyzed to investigate the interactions between CD226 and CD155 as a result of our failure in obtaining the crystals of the hCD226-ecto/hCD155-D1 complex.
The Double-Lock-and-Key Binding Motif Between CD226 and CD155.
The hybrid complex structure of mCD226-ecto and hCD155-D1 was determined to a resolution of 2.2 Å (SI Appendix, Table S1 ). Overall, the complex structure reveals that hCD155-D1 orthogonally binds to the D1 domain of mCD226-ecto (Fig. 4A) . The complex structure buries a total solvent-accessible area of ∼1,475 Å 2 (SI Appendix, Fig. S3 A and B) . No substantial conformational changes were apparent between apo mCD226-ecto and its ligand-bound format, with a root mean square deviation of 0.494 Å over 219 aligned Cα atoms, as is also observed for that of hCD155-D1 (root mean square deviation of 0.48 Å over the 119 aligned Cα atoms; PDB code 4FQP for apo CD155). An N-acetylglucosamine from the N105 of hCD155-D1, which is in the opposite β-sheet face of the receptor binding face and oriented away from the CD226 and CD155 binding interface, is visible (Fig. 4A) . Unlike the heterotetramer shown in the complex structures of TIGIT and CD155, no dimeric formation was observed for mCD226 or CD155, although two pairs of hybrid complexes derived from crystal packing were found in one asymmetric unit.
Detailed interactions within the interface were further characterized. Structural analysis showed that the interactions between mCD226-ecto and hCD155-D1 mainly involve residues at the distal ends of the individual AGFCC′C″ sheets of the mCD226-ecto D1 domain and hCD155-D1 (Table 1 and SI Appendix, Fig. S3D ). The interactions were grouped into three subsets. First, the binding of these two molecules is mainly mediated by a double-key-and-lock motif, as observed in the structure of the class-I MHC-restricted T cell-associated molecule (CRTAM) in complex with Necl-2 (17) . Each molecule possesses a protruding key-like structure of an aromatic residue in the FG loop, F114 in mCD226-D1 and F128 in hCD155-D1 (Fig. 4B) . Both of them latch into shallow lock pits, which are formed by the residues from the C′C″ loop, C′, and C″ strands of the opposing molecules via van der Waals' forces and hydrophobic interactions (Fig. 4C) . Second, the double-key-and-lock binding model is strengthened by four nearby hydrogen bonds, which are formed between residues from mCD226 (Q47, E49, A113, and N116) and residues from hCD155 (Q63, S74, T127, and S132; Fig. 4B ). Third, three extra hydrogen bonds located in the center of the complex interface further stabilize the complex structure (Fig. 4D) . In addition to the interactions between each of the first domains of these two molecules, a hydrogen bond formed by E185 of the D2 domain of mCD226 and G70 of hCD155-D1 is observed in the complex structure. This indicates that the D2 domain contributes to direct interaction with CD155, aside from the supporting of the overall architecture of the CD226 structure (Fig. 4E) .
The residues involved in ligand binding in mCD226 were further investigated in its human homolog. The key-like residue (Y113 in hCD226) and the residues forming primary hydrogen bond interactions in D1 are highly conserved with the exception of one nonconservative substitution (A113 of mCD226 and the corresponding T112 of hCD226) (SI Appendix, Fig. S2 ). Superimposition of hCD226-ecto and ligand-bound mCD226-ecto revealed that the conformation of the residues forming hydrogen bond interactions with hCD155 is highly conserved (Fig. 4F) . These conserved residues, together with the typical motif of the protruding key and the concave pit presenting on the hCD226 surface (SI Appendix, Fig. S3C ), suggest that the CD155 binding mode is similar between hCD226 and mCD226.
D2 Domain of CD226 Aids in Binding to CD155. Protein-based SPR analysis and cell-based flow cytometry analysis were performed to evaluate the key residues involved in the CD226-CD155 interaction and the roles of CD226-D2 in CD155 binding. Four residues in mCD226, including the key-like residue F114 and three residues (Q47, E49, and H68) that participate in hydrogen bond interactions with amino acids surrounding the key-like residue in CD155, were mutated to Arg or Ser to evaluate their influences on the CD226-CD155 interaction. Similarly, two residues in hCD155-D1, including the key-like residue F128 and Q63 that forms multiple hydrogen bond interactions with the key-like residue in mCD226, were chosen and simultaneously substituted by Arg to test the roles they might play in CD226-CD155 recognition. The SPR analyses indicated that mutations of mCD226 protein with Q47A, H68A, and F114A would substantially decrease the binding capacity to CD155 (Fig. 5A and SI Appendix, Fig. S4A ). No binding between CD155 and the quadruple-mutant of mCD226 (F114R/Q47R/E49R/H68S, named mCD226-4M) could be detected (Fig. 5A) . Specifically, F114A mutation exhibited similar binding capacity to mCD226-4M, indicating the important roles of key-like residue in the interaction with CD155. Similarly, no binding to either human or mouse CD226 was observed with the double-mutant of CD155 (Q63R/F128R, named hCD155-D1-2M; Fig. 5 A and B) .
However, the corresponding hCD226-ecto mutant (Y114R/ Q47R/E49R/H67S) possessed an extremely reduced refolding efficiency that hindered the SPR experiments. Therefore, the interaction between hCD226 and CD155 was further investigated using flow cytometry analysis. The wild-type or quadruplemutant of the Fc-fused hCD226-ecto proteins were expressed in 293T cells, and their binding to CD155 was assessed via staining of CHO-K1 cell lines stably expressing full-length CD155-GFP on the cell surface. The proper surface localization of CD155 was evidenced by staining with a CD155-specific antibody (Fig. 5C) . Compared with the substantial staining of wild-type hCD226, the quadruple-mutant of hCD226 displayed no binding to CD155 (Fig. 5C) . Together with the SPR results, these findings suggest that hCD226 uses a similar mechanism to bind to CD155 as its mouse homolog.
To additionally explore the roles of each domain of hCD226 in ligand binding, truncated hCD226 Fc-fused proteins that contained either the D1 or D2 domain were produced. We found that hCD226-D2 exhibited no staining to CD155-expressing cells. In contrast, although staining with the hCD226-D1 domain alone could be detected in the absence of D2 domain, the binding ratio was substantially reduced compared with the two-domain hCD226-ecto (Fig. 5D) . The attenuated hCD226-D1/CD155 interaction was further confirmed by staining CD155-GFP-positive cells with serially diluted hCD226-ecto and hCD226-D1 proteins (Figs. 5 E and F and SI Appendix, Fig. S4 ). The titrations of the hCD226-ecto and hCD226-D1 proteins revealed drastic differences in binding (Fig. 5G) . These results indicate the essential roles of the D1 domain in the CD226-CD155 interaction and the complementing roles of the D2 domain in CD226 recognition to its ligand.
Discussion
In this study, we report the crystal structure of the ectodomain of both hCD226 and mCD226 with a unique side-by-side arrangement pattern of the two tandem IgV domains, which is distinct from the conventional head-to-tail organizing mode of Ig-like superfamily members. This unique arrangement is mainly mediated by A strand of D1 domain, which forms a D1-A-strandcentric hydrogen bond network between the D1 and D2 domains. This unique arrangement connects the two AFGCC′C″ sheets of both D1 and D2 to form a super β-sheet consisting of 11 β-strands. Therefore, the two domains of CD226 were linked with more rigidity. The arrangement of the Ig-like domains of a receptor or ligand that contains multiple Ig-like domains may be correlated with the accessibility to its counterparts. A flexible connection between sequential Ig-like domains might facilitate the binding to ligand/receptor via the adaption of the binding orientations (34) . Moreover, the interdomain angle might further affect the possibility for interaction with the ligand/receptor (32) . Structural analysis of TIGIT, a well-studied molecule in the CD226-CD96-TIGIT family, revealed that it can form both cisand trans-heterodimers with its ligands on the cell surface (18, 30) . Therefore, the lack of plasticity between the domains in CD226 may be potential obstacle to the accessibility to CD155 or CD112 if it adopts a similar ligand binding mode as TIGIT. The C-terminal residues (A242 to T250) of hCD226-ecto were missing in the determined structure, indicating the flexibility of the loop connecting the functional domains and transmembrane region (Fig. 4A) . We propose that this flexible hinge loop, together with the conformational flexibility of the nectin/Necl family member ligands, compensates for the dexterity of CD226 in ligand binding.
Structural studies of VCBP3, an amphioxus immune-type receptor that contains two N-terminal IgV-like domains and a C-terminal chitin-binding domain, demonstrate that it exhibits a similar side-by-side arrangement pattern of the two IgV domains to CD226. However, the VCBP3 structure centers on each G strand flank with rotational symmetry (35) . Ig-like molecules containing one V-set domain and one or more C-set domains usually adopt head-to-tail tandem arrangement patterns of the Iglike domains. It seems that the side-by-side arrangement mode might be a unique structural feature of Ig-like molecules with multiple sequential V-set domains. This hypothesis proposes a perspective in structural studies of multiple Ig-domain molecules and should be further verified.
The complex structure of CD226 and CD155 revealed the interaction of these two molecules via a similar binding motif to TIGIT and CD155/CD112, a typical double-lock-and-key motif (18, 30) . Mutagenesis demonstrated that the binding motif of hCD226 and mCD226 to CD155 is similar. By investigating the residues involved in the complex formation, we found that most of the important residues in CD226-D1 are mainly located in three regions, which are similar to the previously defined (V/I)(S/T)Q, AX 6 G, and T(F/Y)P motifs (SI Appendix, Fig. S2 ) (18) . These regions exist in the membrane-distal D1 domain of CD226 and are relatively conserved among CD226-TIGIT-CD96 and nectin/Necl family members (15) . Similarly, the structures of both the CD155 transhomodimer and TIGIT-CD155 complex revealed that both the trans interactions between CD155s and the recognition of TIGIT to CD155 or CD112 are mediated by these (V/I)(S/T)Q, AX 6 G, and T(F/Y)P motifs and presented a similar binding interface to that Table 1 . Interaction between hCD155-D1 and mCD226-D1D2
hCD155-D1
Contacts* mCD226-D1D2   H60  1, 8  N67, H68  S62  2, 1, 4  T46, Q47, N65  Q63  7, 1, 8, 3, 1  T46, H112, A113, F114, G117  T65  1  P118  G70  4  E185  S74  1, 5, 2, 2  P115, N116, G117, P118  V77  2, 3, 2  F114, P115, G117  H79  6, 9  T46, F114  Q80  3  N67  Q82  14  F114  G83  4  F114  P84  3  F114  S85 2 *Numbers represent the number of atom-to-atom contacts between the hCD155-D1 residues and the mCD226-D1D2 residues, which were analyzed by the Contact program in CCP4 suite (the distance cutoff is 4.5 Å).
of the CD226-CD155 complex (SI Appendix, Fig. S5 ) (18, 30) . Together with other complex structures, the binding of CD226 to CD155 reveals a typical recognition pattern of paired CD226-TIGIT-CD96 family receptors and nectin/Necl family ligands, which participate in both cell adhesion and immune recognition.
Aside from the conserved interface in the D1 domain, our work has also provided strong evidence that the D2 domain of CD226 also participates in CD155 binding. Structural analysis reveals that amino acids in the D2 domain directly contact CD155. The CD155 staining efficiency of truncated CD226-D1 was substantially reduced, indicating the important roles of the D2 domain of CD226 in binding to CD155. In fact, the CD226-TIGIT-CD96 family members contain varied numbers of Ig-like domains, as the TIGIT, CD226, and CD96 molecules possess one, two, and three extracellular Ig-like domains, respectively. Furthermore, alternative gene splicing of CD96 results in two isoforms that differ in the middle Iglike domain, either V-set or C/I-set (36) . Similarly, Meyer and colleagues report that the interaction between CD96 and CD155 is affected by the two downstream domains, and a mutation (T280M) in the third domain of CD96 results in substantially reduced binding affinity to CD155 (36) . Taken together, these data sketch a ligand binding model for the CD226-TIGIT-CD96 family in which the conserved double-lock-and-key binding mode in the membranedistal Ig domains dominates the ligand binding, whereas the other domains provide supportive architecture or direct interactions with the ligands.
The CD226-TIGIT-CD96 family members synergistically regulate the function of NK cells. Although these receptors share the same ligands, the inhibitory receptors maintain binding priority over stimulatory receptors, which is proposed to be the mechanism for preventing the CD226-mediated chronic activation of NK cells (8) . However, the mechanism of this "inhibitory receptors first" hypothesis in ligand binding of CD226 is not fully understood. It is hypothesized that they may use a similar affinity-discrepancy model, as observed in paired receptors of T cells; for example, the inhibitory receptor CTLA-4 possesses higher binding affinity for CD80/86 than the stimulatory receptor CD28 (37) . In this study, we found that the binding affinity between hCD226 and CD155 is six times greater than the previously reported affinity between hCD226 and CD112 (8.97 μM) (38) . These results are in accordance with the phenomenon that CD226-Fc protein binds more efficiently to CD155-overexpressing cells than to CD112 (23) . However, the binding affinity of hCD226 for CD155 exhibited no substantial difference with that of the inhibitory TIGIT to CD155 (3.2 μM), as reported in previous studies (30) . This affinity discrepancy contradicts the aforementioned "inhibitory receptors first" hypothesis and indicates that the CD226-TIGIT-CD96 family may use a different mechanism to coordinate the NK cell activation and inhibition.
In summary, we report a unique side-by-side arrangement of the two IgV domains of CD226. It binds to CD155 through the D1 domain, with a similar binding motif to that of the paired inhibitory receptor TIGIT and its nectin/Necl family ligands. The findings that the D2 domain of CD226 provided both supportive architecture for the D1 domain and direct interaction with CD155 indicate the critical roles of the unique structural arrangement in ligand binding. All these findings increase our understanding of NK cell activation and will facilitate future development of biologics targeting CD226 for immunotherapy.
Materials and Methods
Protein Expression and Purification. To express the hCD226-ecto and mCD226-ecto proteins used for crystallization, the cDNAs encoding residues 19-250 of hCD226 (GenBank: NM_001303618.1) and 21-243 of mCD226 (GenBank: NM_001039149.1) were individually cloned into the NdeI and XhoI sites of the pET-21a vector (Invitrogen). The h/mCD226-ecto mutant proteins were constructed by site-directed mutagenesis. These recombinant proteins were expressed in E. coli strain BL21 (DE3) as inclusion bodies and refolded via a previously described dialysis method (38, 39) . The first Ig-like domain of CD155 (hCD155-D1, residues 1-143) fused to a C-terminal hexahistidine tag was ligated into the BamHI and XhoI sites of the pFastbac-1 vector (Invitrogen) and expressed with the Bac-to-Bac baculovirus expression system, as previously described (40) . After preparation, these soluble proteins were then purified by gel-filtration on a Superdex 200 100/300 GL column (GE Healthcare; for hCD226-ecto), a Hiload 16/60 Superdex 200 PG column (GE Healthcare; for mCD226-ecto), or a Hiload 16/60 Superdex 75 PG column (GE Healthcare; for hCD155-D1), and concentrated for crystal screening and SPR experiments.
To obtain the complex of mCD226-ecto and hCD155-D1, each of the proteins was mixed in vitro at a molar ratio of 1:1 and then incubated overnight at 4°C. After purification on a Superdex 200 100/300 GL column (GE Healthcare), the fractions containing the complex were collected and concentrated to ∼10 mg/mL for crystal screening.
To obtain the Fc-fused proteins used in the flow cytometry assay, the fragments encoding the ectodomain of wild-type or mutant hCD226 (residues 1-250) or the D1 (residues 1-129) or D2 domain of hCD226 (residues 1-18, 130-250) were cloned into the pCAGGS expression vectors that contain the fragment encoding the Fc domain of mouse IgG (mFc) at the C terminus. The expression plasmids were then transfected into HEK 293T cells (ATCC). The cell culture was collected 72 h after transfection and then purified with a protein A column and by size exclusion chromatography with a Superdex 200 100/300 GL column (GE Healthcare) equilibrated with PBS.
Crystallization, Data Collection, and Structure Determination. Both hCD226-ecto native protein and mCD226-ecto protein were crystallized by the sitting drop vapor diffusion method. To be specific, 1 μL protein solution was mixed with 1 μL reservoir solution containing 0.1 M Tris at pH 7.5 and 0.8 M Na/K hydrogen phosphate (for hCD226-ecto) or 0.1 M Na Hepes at pH 7.5, 10% (wt/vol) PEG 8000, and 8% (vol/vol) ethylene glycol (for mCD226-ecto) at 4°C. The hCD226-ecto native crystals were used to streak-seed selenomethionine-substituted crystals. For the mCD226/CD155 complex, crystals were grown in 0.1 M Tris at pH 8.0, 0.15 M ammonium sulfate, and 15% (wt/vol) PEG4000 at 18°C.
For data collection, all crystals were briefly soaked in their individual reservoir solutions supplemented with 20% (vol/vol) glycerol and flash-cooled in liquid nitrogen. All data sets were collected at the Shanghai Synchrotron Radiation Facility beamline BL17U, at a temperature of 100 K and then indexed, integrated, and scaled with HKL2000 (41) .
The crystal structure of hCD226 was solved by single wavelength anomalous dispersion phasing. The selenomethionine sites were located with SHELXD (42) and were used to calculate phases with Phaser (43) from the CCP4 program suite (44) . The initial phase was improved by density modification with DM (45), followed by automatic model building with ARP/wARP (46) . The structure of mCD226-ecto/hCD155-D1 was solved by molecular replacement using Phaser with the structures of mCD226-ecto and hCD155 (PDB code: 3EOW) as search models. Initial restrained rigidbody refinement and manual model building were performed using REFMAC5 (47) and COOT (48) , respectively. Further rounds of refinement were performed using phenix.refine (49) . The stereochemical quality of the final model was assessed with the program PROCHECK (50) . Data collection, processing, and refinement statistics are summarized in SI Appendix, Table S1 . All structural figures were generated using Pymol (https://pymol.org/2/).
Thermofluor Assay. Thermofluor experiments were performed with a iCycleriQ Real Time PCR Detection System (Bio-Rad) instrument. The fluorescent dye SYPRO Orange (Invitrogen) was used to monitor the denaturation of the proteins. Twenty-microliter reactions were set up in a PCR plate containing 10 μM of each protein and 5× SYPRO Orange solutions. For each sample, three replicates were performed. The plate was then heated from 20°C to 95°C in increments of 0.5°C/30 s. The fluorescence signals were recorded and the mean value of the derivatives were plotted as a function of temperature.
SPR Analysis. SPR analysis was performed using a BIAcore 3000 machine with the CM5 sensor chip (GE Healthcare) at room temperature (25°C). All of the proteins used in these experiments were exchanged into SPR buffer that contains 10 mM Hepes·HCl at pH 7.5, 150 mM NaCl, and 0.005% (vol/vol) Tween-20 via gel-filtration. The wild-type hCD155-D1 protein (hCD155-D1-WT) or hCD155-D1-2M protein were individually immobilized on different channels of the CM5 chip to ∼1,000 response units, and then the serially diluted analytes were flowed through the chip. The binding kinetics were analyzed with the software BIAevaluation Version 4.1 using a 1:1 Langmuir binding model.
Flow Cytometry Assay.
For the construction of cell lines stably expressing CD155, the full-length human CD155 cDNA was cloned into the pEGFP-N1 vector and transfected into the CHO-K1 cell line. Fresh medium containing 800 μg/mL Geneticin (Thermo Fisher) was added to the cells 48 h after transfection, and the medium was refreshed every few days until the appearance of megascopic cell foci. The cells stably expressing CD155 were then identified and sorted via flow cytometry.
For cell staining, the preprepared Fc-fused proteins of hCD226-ecto-WT and hCD226-D1 were serially diluted (the target concentrations are shown in SI Appendix, Fig. S4 ), whereas the Fc-fused proteins of hCD226-ecto-4M and hCD226-D2 were prepared at a concentration of 700 nM. The native CHO-K1 cells or CHO-K1 cells stably expressing CD155-GFP were then suspended in PBS and incubated with the either the murine antibody specific to CD155 (sc-514623; Santa Cruz Biotechnology) or the Fc-fused proteins for 0.5 h at 4°C. The cells were then rinsed and further incubated with APC-conjugated anti-mouse secondary IgG antibody (CAT: 405308; Biolegend) for an additional 0.5 h at 4°C before bring analyzed by flow cytometry analysis. The cells incubated only with the secondary antibodies were used as negative controls.
Analytical Gel Filtration. The hCD226-ecto and mCD226-ecto proteins were individually mixed with hCD155-D1 protein at a molar ratio of 1:2, and incubated for 4 h at 4°C. The hCD226-ecto, mCD226-ecto, and hCD155-D1 proteins and their mixture were adjusted to the same volume. The samples were then loaded onto a calibrated Superdex 200 column (GE Healthcare). The chromatographs were recorded and overlaid onto each other. The pooled proteins were analyzed on a 15% SDS/PAGE gel and stained with Coomassie blue.
Data Availability. The atomic coordinates of hCD226-ecto, mCD226-ecto, and mCD226-CD155 complex have been deposited into the Protein Data Bank database under the accession codes 6ISA, 6ISB, and 6ISC, respectively.
